Foghorn Therapeutics Inc (FHTX) returns
Foghorn Therapeutics returns over 5 years
$1,000 invested in Foghorn Therapeutics five years ago was worth $163.91 at the close on October 30, 2026, with dividends reinvested: an average return of -30.4% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -41.7% | — | $582.63 | -0.9% |
| 3 months | -56.1% | — | $438.82 | +2.1% |
| Year to date | -61.5% | — | $385.19 | +11.7% |
| 1 year | -51.7% | — | $482.60 | +12.4% |
| 3 years | -40.4% | -15.8% | $595.99 | +88.5% |
| 5 years | -83.6% | -30.4% | $163.91 | +76.0% |
Foghorn Therapeutics return by calendar year
| Year | FHTX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -61.5% | +11.7% | -73.2% |
| 2025 | +14.4% | +17.7% | -3.3% |
| 2024 | -26.8% | +24.9% | -51.7% |
| 2023 | +1.1% | +26.2% | -25.1% |
| 2022 | -72.1% | -18.2% | -53.9% |
| 2021 | +12.8% | +28.7% | -15.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: FHTX financials
No forecast, no recommendation. This page describes Foghorn Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.